Aleš Kvasnička

Novel LC-MS tools for diagnosing inborn errors of metabolism

D. Friedecký, Eliška Ivanovová, Barbora Piskláková, 2021 .

Lipidomic and metabolomic analysis reveals changes in biochemical pathways for non-small cell lung cancer tissues.

M. Holčapek, K. Míčová, D. Friedecký, 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.

Altered Plasma, Urine, and Tissue Profiles of Sulfatides and Sphingomyelins in Patients with Renal Cell Carcinoma

B. Melichar, K. Polański, M. Holčapek, 2022, medRxiv.

Clinical lipidomics in the era of the big data

L. Najdekr, D. Friedecký, Eliška Ivanovová, 2023, Clinical chemistry and laboratory medicine.

Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients

J. Procházková, D. Friedecký, L. Slavík, 2021, Diagnostics.

Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for analysis of organic acids, acylglycines, and acylcarnitines in urine

T. Adam, D. Friedecký, E. Hlídková, 2023, Clinical Chemistry and Laboratory Medicine.

SLIDE—Novel Approach to Apocrine Sweat Sampling for Lipid Profiling in Healthy Individuals

Z. Zadák, L. Najdekr, H. Janečková, 2021, International journal of molecular sciences.

Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies

D. Friedecký, A. Kováč, P. Majerová, 2023, bioRxiv.

Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition

D. Friedecký, P. Šácha, D. Dobešová, 2024, ACS chemical neuroscience.